`Indian pharma must balance generics with innovation’
[ad_1] NEW DELHI: India’s pharmaceutical industry must focus on both generics and innovative products, as well as develop products specially tailored for the country’s patient needs. Domestic companies particularly smaller to mid-sized players can carve out a strong role in rare diseases and niche patient segments, where agility and specialised research can drive meaningful breakthroughs,…